Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
invoX Pharma
|
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:focusesOn |
immuno-oncology
bispecific antibodies |
| gptkbp:foundedIn |
2006
|
| gptkbp:founder |
gptkb:John_McCafferty
|
| gptkbp:headquartersLocation |
gptkb:Cambridge,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
F-star Biotechnology
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:parentCompany |
invoX Pharma
|
| gptkbp:specializesIn |
antibody engineering
therapeutic antibodies |
| gptkbp:website |
https://www.f-star.com/
|
| gptkbp:bfsParent |
gptkb:Takeda
|
| gptkbp:bfsLayer |
6
|